• Rubicon Organics (ROMJ) has received the first purchase order from Cannabis NB
  • The purchase order is for Rubicon’s 1964 Organic Apple Toffee flower product
  • Rubicon Organics Inc. is becoming the global brand leader in organic cannabis products
  • Through its wholly-owned subsidiary Rubicon Holdings Corp it cultivates, processes and sells organically certified, sustainably produced, super-premium cannabis products
  • Rubicon Organics Inc. (ROMJ) is down 3.77 per cent and is trading at C$2.55 at 12:50 pm ET

Rubicon Organics Inc. (ROMJ) has received its first purchase order from Cannabis NB, New Brunswick’s provincial cannabis distributor and retailer.

The purchase order is for Rubicon’s 1964 Organic Apple Toffee flower product, a part of Rubicon Organics’ premium organic flower and hash product line, 1964 Supply Co™.

“Rubicon Organics is now officially coast-to-coast, and our products are available to consumers in eight provinces and territories. Just as importantly, we have begun the national rollout of 1964 Supply Co™ which was launched in Québec earlier this year,” said Jesse McConnell, Chief Executive Officer.

“Having a premium flower brand alongside our flagship super-premium Simply Bare™ Organic brand available across Canada is a significant step in our innovation strategy as we seek to maintain and extend our market share in the premium and organic segments of the cannabis market,” added McConnell.

Rubicon Organics Inc. is becoming the global brand leader in organic cannabis products.

Through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer, the Company cultivates, processes and sells organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art hybrid greenhouse located in Delta, BC, Canada.

Rubicon Organics Inc. (ROMJ) is down 3.77 per cent and is trading at C$2.55 at 12:50 pm ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.